ForthRight Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-85
Closed -$5K 53
2020
Q4
$5K Buy
+85
New +$5.23K ﹤0.01% 148

Other funds holding BMY

ForthRight Wealth Management's BMY Position: Q1 2021 in Review

ForthRight Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 85 shares — an estimated $5K sold.

ForthRight Wealth Management first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • ForthRight Wealth Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • ForthRight Wealth Management sold 85 Bristol-Myers Squibb shares in Q1 2021, an estimated $5K.
  • ForthRight Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
  • ForthRight Wealth Management's Bristol-Myers Squibb position peaked at $5K in Q4 2020.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on ForthRight Wealth Management's 13F filing for Q1 2021, filed 26 Apr 2021.